Intrinsic Value of S&P & Nasdaq Contact Us

CRISPR Therapeutics AG CRSP

NASDAQ Global Market

SharesGrow Score
48/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$65.00
+14.3%

CRISPR Therapeutics AG (CRSP) current share price is $56.86. The gold spot price is $4,808.10 per troy ounce. Using the formula: CRSP in gold = $56.86 × 31.1035 ÷ $4,808.10 = 0.3678 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of CRSP when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding CRSP shares over the measured period.

CRSP in US Dollars
Gold in US Dollars
CRSP in Gold (grams per share)

Real Wealth Growth Rate

CRSP
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{CRSP}_{\text{gold}}(t) = \frac{P_{\text{CRSP}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{CRSP}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{CRSP}_{\text{gold}}^{(T)}}{\text{CRSP}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{CRSP}_\text{gold}^{(0)}$ = initial gold-price, $\text{CRSP}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

NVO
NVO
Novo Nordisk A/S
$39.32
+3.53%
REGN
REGN
Regeneron Pharmaceuticals, Inc.
$755.51
+1.21%
KRYS
KRYS
Krystal Biotech, Inc.
$270.00
+0.97%
BEAM
BEAM
Beam Therapeutics Inc.
$30.30
+0.40%
SRPT
SRPT
Sarepta Therapeutics, Inc.
$22.15
+1.65%
NTLA
NTLA
Intellia Therapeutics, Inc.
$14.78
+3.65%
VERV
VERV
Verve Therapeutics, Inc.
$11.13
+0.27%
EDIT
EDIT
Editas Medicine, Inc.
$3.39
+5.94%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message